Humana Inc (HUM) Shares Bought by AMP Capital Investors Ltd

Share on StockTwits

AMP Capital Investors Ltd increased its stake in Humana Inc (NYSE:HUM) by 0.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 106,528 shares of the insurance provider’s stock after purchasing an additional 549 shares during the quarter. AMP Capital Investors Ltd’s holdings in Humana were worth $31,706,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in HUM. FMR LLC increased its stake in shares of Humana by 12.7% in the 2nd quarter. FMR LLC now owns 12,212,514 shares of the insurance provider’s stock valued at $3,634,811,000 after acquiring an additional 1,374,030 shares in the last quarter. Old Mutual Global Investors UK Ltd. increased its stake in shares of Humana by 213.1% in the 1st quarter. Old Mutual Global Investors UK Ltd. now owns 727,057 shares of the insurance provider’s stock valued at $195,454,000 after acquiring an additional 494,826 shares in the last quarter. Ceredex Value Advisors LLC bought a new stake in shares of Humana in the 1st quarter valued at $107,093,000. Massachusetts Financial Services Co. MA increased its stake in shares of Humana by 80.1% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 741,942 shares of the insurance provider’s stock valued at $199,454,000 after acquiring an additional 329,956 shares in the last quarter. Finally, Unigestion Holding SA bought a new stake in shares of Humana in the 2nd quarter valued at $79,340,000. Institutional investors own 93.00% of the company’s stock.

NYSE HUM opened at $333.88 on Friday. Humana Inc has a 12-month low of $231.90 and a 12-month high of $336.48. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.43 and a quick ratio of 1.43. The firm has a market capitalization of $45.91 billion, a P/E ratio of 28.31, a price-to-earnings-growth ratio of 1.66 and a beta of 0.96.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 1st. The insurance provider reported $3.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.79 by $0.17. Humana had a net margin of 2.48% and a return on equity of 17.43%. The business had revenue of $14.26 billion during the quarter, compared to the consensus estimate of $14.16 billion. During the same quarter last year, the firm posted $3.49 EPS. sell-side analysts expect that Humana Inc will post 14.18 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Shareholders of record on Friday, September 28th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date is Thursday, September 27th. Humana’s dividend payout ratio is 17.08%.

Several analysts have recently weighed in on HUM shares. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Wednesday, August 8th. ValuEngine downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Saturday, June 2nd. Argus lifted their price target on shares of Humana to $375.00 and gave the company a “buy” rating in a research report on Tuesday. Citigroup reissued a “buy” rating and issued a $340.00 price target (up previously from $280.00) on shares of Humana in a research report on Friday, June 1st. Finally, Piper Jaffray Companies lifted their price target on shares of Humana from $355.00 to $380.00 and gave the company an “overweight” rating in a research report on Friday, August 24th. Six analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $328.94.

In other Humana news, SVP Cynthia H. Zipperle sold 1,000 shares of Humana stock in a transaction on Wednesday, June 13th. The shares were sold at an average price of $306.01, for a total transaction of $306,010.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Elizabeth D. Bierbower sold 3,092 shares of Humana stock in a transaction on Thursday, August 16th. The stock was sold at an average price of $330.00, for a total transaction of $1,020,360.00. Following the transaction, the insider now directly owns 14,289 shares in the company, valued at $4,715,370. The disclosure for this sale can be found here. Insiders have sold a total of 92,431 shares of company stock worth $28,602,805 over the last ninety days. Insiders own 0.60% of the company’s stock.

Humana Profile

Humana Inc is a health and well-being company focused on making it easy for people to achieve best health. Its strategy integrates care delivery, the member experience, and clinical & consumer insights to encourage engagement, behavior change, proactive clinical outreach, and wellness for the people.

Read More: Leveraged Buyout (LBO)

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply